UBS upgraded British American Tobacco (BTI) to Buy from Neutral with a price target of 3,900 GBp, up from 3,000 GBp. The firm views the stock’s valuation as too low. British American’s Velo nicotine pouches will accelerate its sales growth, which will enable the company to deliver its 2026 outlook, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTI:
- Menthol ban withdrawal ‘significant positive’ for Altria and BAT, says Citi
- Trump administration withdraws FDA ban on menthol cigarettes
- FDA proposes plan to make cigarettes ‘nonaddictive’ by limiting tobacco
- Reinet offers to sell 43.3M shares of British American Tobacco
- British American Tobacco Advances Share Buyback Initiative